Article
Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5-year follow-up data from the prospective BioCrohn study.
Alimentary pharmacology & therapeutics - 1 Jul 2023
Bokemeyer Bernd, Plachta-Danielzik Sandra, di Giuseppe Romina, Helwig Ulf, Teich Niels, Schmidt Carsten, Hartmann Petra, Sobotzki Christina, Schreiber Stefan
Abstract excerpt
OBJECTIVE: Under the assumption of irreversibility, the Montreal classification provides a unidirectional assessment of the complications and behaviour of Crohn's disease (CD) that does not allow for downstaging. We examined the use of a bidirectional Montreal classification system that can capture disease regression. DESIGN: From the BioCrohn Registry, an inception cohort of patients with CD for ≤12 months...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.